Article Details

Surprise, surprise: AstraZeneca and FibroGen's once-hyped anemia drug roxadustat hits an FDA wall

Retrieved on: 2021-08-11 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

Surprise, surprise: AstraZeneca and FibroGen's once-hyped anemia drug roxadustat hits an FDA wall. View article details on hiswai:

Excerpt

As AstraZeneca and FibroGen explore the next steps for anemia drug roxadustat after an FDA complete response letter, the focus of the med is shifting ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up